330 related articles for article (PubMed ID: 22241961)
41. Adult mouse subventricular zones stimulate glioblastoma stem cells specific invasion through CXCL12/CXCR4 signaling.
Goffart N; Kroonen J; Di Valentin E; Dedobbeleer M; Denne A; Martinive P; Rogister B
Neuro Oncol; 2015 Jan; 17(1):81-94. PubMed ID: 25085362
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of the SDF-1alpha-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice.
Kawaguchi A; Orba Y; Kimura T; Iha H; Ogata M; Tsuji T; Ainai A; Sata T; Okamoto T; Hall WW; Sawa H; Hasegawa H
Blood; 2009 Oct; 114(14):2961-8. PubMed ID: 19657116
[TBL] [Abstract][Full Text] [Related]
43. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
[TBL] [Abstract][Full Text] [Related]
44. Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy.
Zhou W; Guo S; Liu M; Burow ME; Wang G
Curr Med Chem; 2019; 26(17):3026-3041. PubMed ID: 28875842
[TBL] [Abstract][Full Text] [Related]
45. Tissue Expression and Prognostic Role of CXCL12 and CXCR4 in High-grade Serous Ovarian Carcinoma.
Lim H; Kim SI; Kim EN; Lee M; Lee C; Kim JW; Chung HH
Anticancer Res; 2023 Jul; 43(7):3331-3340. PubMed ID: 37351997
[TBL] [Abstract][Full Text] [Related]
46. SDF-1/CXCL12 induces directional cell migration and spontaneous metastasis via a CXCR4/Gαi/mTORC1 axis.
Dillenburg-Pilla P; Patel V; Mikelis CM; Zárate-Bladés CR; Doçi CL; Amornphimoltham P; Wang Z; Martin D; Leelahavanichkul K; Dorsam RT; Masedunskas A; Weigert R; Molinolo AA; Gutkind JS
FASEB J; 2015 Mar; 29(3):1056-68. PubMed ID: 25466898
[TBL] [Abstract][Full Text] [Related]
47. The
Pansy K; Feichtinger J; Ehall B; Uhl B; Sedej M; Roula D; Pursche B; Wolf A; Zoidl M; Steinbauer E; Gruber V; Greinix HT; Prochazka KT; Thallinger GG; Heinemann A; Beham-Schmid C; Neumeister P; Wrodnigg TM; Fechter K; Deutsch AJ
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554271
[TBL] [Abstract][Full Text] [Related]
48. IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis.
Panneerselvam J; Jin J; Shanker M; Lauderdale J; Bates J; Wang Q; Zhao YD; Archibald SJ; Hubin TJ; Ramesh R
PLoS One; 2015; 10(3):e0122439. PubMed ID: 25775124
[TBL] [Abstract][Full Text] [Related]
49. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
Khare T; Bissonnette M; Khare S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
[TBL] [Abstract][Full Text] [Related]
50. CXCR4 blockade with AMD3100 enhances Taxol chemotherapy to limit ovarian cancer cell growth.
Reeves PM; Abbaslou MA; Kools FRW; Poznansky MC
Anticancer Drugs; 2017 Oct; 28(9):935-942. PubMed ID: 28817386
[TBL] [Abstract][Full Text] [Related]
51. [Effect of chemokine CXCL12 and its receptor CXCR4 on proliferation, migration and invasion of epithelial ovarian cancer cells].
Jiang YP; Wu XH; Xing HY; DU XY
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):403-7. PubMed ID: 17697603
[TBL] [Abstract][Full Text] [Related]
52. Amide-sulfamide modulators as effective anti-tumor metastatic agents targeting CXCR4/CXCL12 axis.
Wu R; Yu W; Yao C; Liang Z; Yoon Y; Xie Y; Shim H; Bai R
Eur J Med Chem; 2020 Jan; 185():111823. PubMed ID: 31698158
[TBL] [Abstract][Full Text] [Related]
53. Split Gaussia luciferase for imaging ligand-receptor binding.
Luker KE; Luker GD
Methods Mol Biol; 2014; 1098():59-69. PubMed ID: 24166368
[TBL] [Abstract][Full Text] [Related]
54. Expression of chemokine CXCL12 and its receptor CXCR4 in folliculostellate (FS) cells of the rat anterior pituitary gland: the CXCL12/CXCR4 axis induces interconnection of FS cells.
Horiguchi K; Ilmiawati C; Fujiwara K; Tsukada T; Kikuchi M; Yashiro T
Endocrinology; 2012 Apr; 153(4):1717-24. PubMed ID: 22355073
[TBL] [Abstract][Full Text] [Related]
55. CXCR4 regulates growth of both primary and metastatic breast cancer.
Smith MC; Luker KE; Garbow JR; Prior JL; Jackson E; Piwnica-Worms D; Luker GD
Cancer Res; 2004 Dec; 64(23):8604-12. PubMed ID: 15574767
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases.
Kim SY; Lee CH; Midura BV; Yeung C; Mendoza A; Hong SH; Ren L; Wong D; Korz W; Merzouk A; Salari H; Zhang H; Hwang ST; Khanna C; Helman LJ
Clin Exp Metastasis; 2008; 25(3):201-11. PubMed ID: 18071913
[TBL] [Abstract][Full Text] [Related]
57. Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway.
Xu D; Li R; Wu J; Jiang L; Zhong HA
Curr Top Med Chem; 2016; 16(13):1441-51. PubMed ID: 26369824
[TBL] [Abstract][Full Text] [Related]
58. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.
Ping YF; Yao XH; Jiang JY; Zhao LT; Yu SC; Jiang T; Lin MC; Chen JH; Wang B; Zhang R; Cui YH; Qian C; Wang Jm; Bian XW
J Pathol; 2011 Jul; 224(3):344-54. PubMed ID: 21618540
[TBL] [Abstract][Full Text] [Related]
59. Comparison of cell-based assays for the identification and evaluation of competitive CXCR4 inhibitors.
Van Hout A; D'huys T; Oeyen M; Schols D; Van Loy T
PLoS One; 2017; 12(4):e0176057. PubMed ID: 28410420
[TBL] [Abstract][Full Text] [Related]
60. A role for the CXCR4-CXCL12 axis in the little skate, Leucoraja erinacea.
Hersh TA; Dimond AL; Ruth BA; Lupica NV; Bruce JC; Kelley JM; King BL; Lutton BV
Am J Physiol Regul Integr Comp Physiol; 2018 Aug; 315(2):R218-R229. PubMed ID: 29641231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
